يعرض 1 - 10 نتائج من 16 نتيجة بحث عن '"Benzamides/*therapeutic use"', وقت الاستعلام: 1.37s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المساهمون: NIHR, National Institute for Health Research, Summers, Charlotte [0000-0002-7269-2873], Apollo - University of Cambridge Repository

    المصدر: Trials, Vol 21, Iss 1, Pp 1-3 (2020)
    Wilkinson, T, Dixon, R, Page, C, Carroll, M, Griffiths, G, Ho, L, De Soyza, A, Felton, T, Lewis, K E, Phekoo, K, Chalmers, J D, Gordon, A, Mcgarvey, L, Doherty, J, Read, R C, Shankar-hari, M, Martinez-alier, N, O’kelly, M, Duncan, G, Walles, R, Sykes, J, Summers, C & Singh, D 2020, ' ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial ', Trials, vol. 21, no. 1 . https://doi.org/10.1186/s13063-020-04584-9
    ACCORD Collaborators 2020, ' ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial ', Trials, vol. 21, no. 1, 691 . https://doi.org/10.1186/s13063-020-04584-9
    Trials

    وصف الملف: text; application/pdf

  4. 4

    المصدر: Blood, Vol. 125, No 24 (2015) pp. 3711-3719

    مصطلحات موضوعية: Benzamides / toxicity, Male, Piperazines / administration & dosage, medicine.medical_treatment, Biochemistry, Gastroenterology, Piperazines, Pyrimidines / toxicity, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Medicine, Philadelphia Chromosome, Piperazines / therapeutic use, Protein Kinase Inhibitors / therapeutic use, Piperazines / toxicity, ddc:616, Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy, Protein Kinase Inhibitors / administration & dosage, Antineoplastic Combined Chemotherapy Protocols / toxicity, Hematology, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Middle Aged, Pyrimidines / administration & dosage, Treatment Outcome, Benzamides, Imatinib Mesylate, Female, Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy, medicine.drug, Adult, medicine.medical_specialty, Vincristine, Adolescent, Cyclophosphamide, Benzamides / therapeutic use, Immunology, Benzamides / administration & dosage, Disease-Free Survival, Young Adult, Internal medicine, Acute lymphocytic leukemia, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Pyrimidines / therapeutic use, Humans, Protein Kinase Inhibitors, Protein Kinase Inhibitors / toxicity, Chemotherapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics, business.industry, Imatinib, Cell Biology, Antineoplastic Combined Chemotherapy Protocols / administration & dosage, medicine.disease, Surgery, Transplantation, Regimen, Pyrimidines, Imatinib mesylate, business, Stem Cell Transplantation

  5. 5
  6. 6

    المصدر: Molecular Vision

    وصف الملف: application/pdf

  7. 7
  8. 8

    المصدر: The Journal of biological chemistry, 285 (3

    وصف الملف: 2 full-text file(s): application/pdf; application/pdf

  9. 9
  10. 10